Chuan-Chuan Chao
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Chuan-Chuan Chao has a total of 5 co-authors. Here are the top co-authors by number of shared publications:
- Hsing-Jien Kung
Institute of Molecular and Genomic Medicine, National Health Research Institutes, Zhunan, Taiwan
1 shared publication - Po-Wen Shen
Program in Molecular Medicine, National Yang Ming Chiao Tung University and Academia Sinica, Taipei 112, Taiwan
1 shared publication - Ting-Fen Tsai
Department of Life Sciences and Institute of Genome Sciences, National Yang Ming Chiao Tung University, Taipei, Taiwan, ROC
1 shared publication - Tsai-Yu Tzeng
Cancer Progression Research Center, National Yang Ming Chiao Tung University, Taipei 112, Taiwan
1 shared publication - Yu-Hui Wong
Brain Research Center National Yang Ming Chiao Tung University Taipei Taiwan
1 shared publication
Latest Publications
- Open Access
- 7 November 2021
- Published by MDPI AG in Biomedicines
- Vol. 9 (11) , 1635
Human iPSC-Derived Neurons as A Platform for Deciphering the Mechanisms behind Brain Aging
With an increased life expectancy among humans, aging has recently emerged as a major focus in biomedical research. The lack of in vitro aging models—especially for neurological disorders, where access to human brain tissues is limited—has hampered the progress in studies on human brain aging and various age-associated neurodegenerative diseases at the cellular and molecular level. In this review, we provide an overview of age-related changes in the transcriptome, in signaling pathways, and in relation to epigenetic factors that occur in senescent neurons. Moreover, we explore the current cell models used to study neuronal aging in vitro, including immortalized cell lines, primary neuronal culture, neurons directly converted from fibroblasts (Fib-iNs), and iPSC-derived neurons (iPSC-iNs); we also discuss the advantages and limitations of these models. In addition, the key phenotypes associated with cellular senescence that have been observed by these models are compared. Finally, we focus on the potential of combining human iPSC-iNs with genome editing technology in order to further our understanding of brain aging and neurodegenerative diseases, and discuss the future directions and challenges in the field.
- 7 November 2021
- Published by MDPI AG in Biomedicines
- Vol. 9 (11) , 1635
Open AccessHuman iPSC-Derived Neurons as A Platform for Deciphering the Mechanisms behind Brain Aging
With an increased life expectancy among humans, aging has recently emerged as a major focus in biomedical research. The lack of in vitro aging models—especially for neurological disorders, where access to human brain tissues is limited—has hampered the progress in studies on human brain aging and various age-associated neurodegenerative diseases at the cellular and molecular level. In this review, we provide an overview of age-related changes in the transcriptome, in signaling pathways, and in relation to epigenetic factors that occur in senescent neurons. Moreover, we explore the current cell models used to study neuronal aging in vitro, including immortalized cell lines, primary neuronal culture, neurons directly converted from fibroblasts (Fib-iNs), and iPSC-derived neurons (iPSC-iNs); we also discuss the advantages and limitations of these models. In addition, the key phenotypes associated with cellular senescence that have been observed by these models are compared. Finally, we focus on the potential of combining human iPSC-iNs with genome editing technology in order to further our understanding of brain aging and neurodegenerative diseases, and discuss the future directions and challenges in the field.